ArriVent BioPharma, Inc. (NASDAQ:AVBP) institutional investors have had a good week as stock gains 19%

ArriVent BioPharma, Inc. ownership breakdown reveals institutions with a 43% stake. Hedge funds own 5.8%, with top 8 shareholders holding over half. Insider ownership is at US$10.